Background Many countries offer a second BCG vaccination to prevent tuberculosis, although
there is little evidence of whether this confers additional protection. BCG vaccination is …

Pneumonia is most problematic for children in developing countries. In 2010, Brazil introduced
a 10-valent pneumococcal conjugate vaccine (PCV10) to its National Immunization …

… Tanno and Ana L. Bierrenbach designed the study, analyzed and interpreted the data, and
wrote the manuscript. Fernando Ganem, Cristiana Toscano, and Pascal Demoly helped in …

In contrast to the majority of allergic or hypersensitivity conditions, worldwide anaphylaxis
epidemiological data remain sparse with low accuracy, which hampers comparable morbidity …

Background The effectiveness of anti-parasite treatment with benznidazole in the chronic
Chagas disease (ChD) remains uncertain. We evaluated, using data from the NIH-sponsored …

Routine infant immunization with 10-valent pneumococcal conjugate vaccine (PCV-10) began
in Brazil in 2010. The impact of the PCV-10 on rates of invasive pneumococcal disease (…

Introduction Limited population-based epidemiologic information about sepsis’ demography,
including its mortality and temporal changes is available from developing countries. We …

Tuberculosis (TB) ranks among the 10 principal causes of death and disability worldwide,
largely on the basis of mortality estimates. These estimates have been derived by a variety of …

Background Bacterial meningitis is associated with significant burden in Brazil. In 2010,
both 10-valent pneumococcal conjugate vaccine and meningococcal capsular group C …

Purpose We have established a prospective cohort of 1959 patients with chronic Chagas
cardiomyopathy to evaluate if a clinical prediction rule based on ECG, brain natriuretic peptide (…